Mesoblast Limited American Depositary Shares — Quarterly Financial Statements (NASDAQ:MESO)

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Market Capitalization N/A
Employee 81
Founded 2004
CEO Silviu Itescu
Website www.mesoblast.com
Headquarter Australia
FIGI BBG000QD6LZ1
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

— Market capitalization

Price to earnings ratio

—

Price to sales ratio

—

Dividends per share

—

Dividend yield %

—

Mesoblast Limited - American Depositary Shares

Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

Haberler

Mesoblast H1 FY26 slides: first approved MSC product hits $49M

Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication - Mesoblast (NASDAQ:MESO)

FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain - Mesoblast (NASDAQ:MESO)

Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session - American Express (NYSE:AXP), Bread Finl Hldgs (NYSE:BFH)

Il titolo Mesoblast raggiunge il massimo di 52 settimane a 21,05 USD

Mesoblast stock reaches 52-week high at 21.05 USD

Mesoblast Stock Rises On Strong Year‑Over‑Year Growth In Ryoncil Sales - Mesoblast (NASDAQ:MESO)

Mesoblast annuncia cambiamenti nella leadership del consiglio di amministrazione

Mesoblast announces board leadership changes as company evolves

Urban Outfitters, Arrowhead Pharmaceuticals, Petco Health and Wellness And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma (NASDAQ:ARWR), Duolingo (NASDAQ:DUOL)

MESO